Link
Regulatory Decision Summary - Pfizer-BioNTech COVID-19 Vaccine - Health Canada
Organization: Public Health Agency of Canada (PHAC)Published: 2020
"This webpage provides information about the regulatory decision summary by Health Canada for the Pfizer-BioNTech COVID-19 vaccine." - Public Health Agency of Canada
Resource Group:
Implementation Tool
Product Type: Policy
Research and Development
Vaccine Ingredients
Policy
Immunization Policies
Evaluations
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Policy
Category:
Vaccine Safety and Development,Research and Development,Vaccine Ingredients,Policy,Immunization Policies,Evaluations,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and DevelopmentResearch and Development
Vaccine Ingredients
Policy
Immunization Policies
Evaluations
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Audience:
Health Care Professional
Region: National
Region: National
Language:
English
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.